


KYLYS
Pharmaceutical Manufacturing • Plan-les-Ouates, Geneva, Switzerland • 1-10 Employees
Company overview
| Headquarters | Route de la Galaise 34, C/O FONGIT, Plan-les-Ouates, Geneva 1228, CH |
| Website | |
| NAICS | 3254 |
| SIC | 873 |
| Founded | 2017 |
| Employees | 1-10 |
| Socials |
Key Contact at KYLYS
Olivier Jordan
CEO, co-founder
About KYLYS
KYLYS is a Life Science Spin-off from the University of Geneva, now ready to step into clinical development. Passionate about science and biotechnology, we are committed to developing a unique technology to deliver highly effective and safe products based on the next generation of hyaluronic acid (HA). Our products are aesthetic (KYLYS Aesthetics) and medical (KYLYS). Our technology can revolutionize HA delivery for medical and surgical needs, in the field of: Aesthetic Rheumatology Reconstructive surgery Drug delivery system Veterinary
KYLYS revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $821,328 |
| Total funding | $111,600 |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
KYLYS has 1 employees across 1 departments.
Departments
Number of employees
KYLYS Tech Stack
Discover the technologies and tools that power KYLYS's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
Web servers
Font scripts
JavaScript libraries
Programming languages
Security
Blogs
Page builders
Hosting
Frequently asked questions
4.8
40,000 users



